Mast Cell Survival and Mediator Secretion in Response to Hypoxia

Abstract

Tissue hypoxia is a consequence of decreased oxygen levels in different inflammatory conditions, many associated with mast cell activation. However, the effect of hypoxia on mast cell functions is not well established. Here, we have investigated the effect of hypoxia per se on human mast cell survival, mediator secretion, and reactivity. Human cord blood derived mast cells were subjected to three different culturing conditions: culture and stimulation in normoxia (21% O2); culture and stimulation in hypoxia (1% O2); or 24 hour culture in hypoxia followed by stimulation in normoxia. Hypoxia, per se, did not induce mast cell degranulation, but we observed an increased secretion of IL-6, where autocrine produced IL-6 promoted mast cell survival. Hypoxia did not have any effect on A23187 induced degranulation or secretion of cytokines. In contrast, cytokine secretion after LPS or CD30 treatment was attenuated, but not inhibited, in hypoxia compared to normoxia. Our data suggests that mast cell survival, degranulation and cytokine release are sustained under hypoxia. This may be of importance for host defence where mast cells in a hypoxic tissue can react to intruders, but also in chronic inflammations where mast cell reactivity is not inhibited by the inflammatory associated hypoxia.

Hypoxia: a critical regulator of early human tendinopathy

“…Inhibition of ERK in hypoxia significantly reduced cytokine production and thus may provide a mechanism for reducing proinflammatory molecular events in tendinopathy. We and others have highlighted the key role of a large mast cell infiltrate in tendinopathy,33 37 38 and this combined with evidence from Gulliksson et al 39 demonstrating hypoxic-induced IL-6 production in mast cells, adds growing importance to the role of chemokines in the initiation and perpetuation of the inflammatory cascade in tendon biology (figure 6C). …”

Human mast cells and basophils—How are they similar how are they different?

“…A plethora of factors present in TME such as SCF, 429 VEGFs 238,252,219 , hypoxia, 455 adenosine, 456 PGE 2 238 can influence mast cell recruitment and activation. Moreover, several chemokines (CXCL1, CXCL10, and CXCL12), 252,457 cytokines (IL-33, IFNγ) 88,89,458 and immune complexes 459 can activate TAMCs in TME.…”

Controversial role of mast cells in skin cancers

“…Several factors within the tumor microenvironment have the potential to activate TAMCs. Hypoxia, a prominent feature of the tumor microenvironment, activates human mast cells to release IL‐6 and VEGF‐A . Adenosine, generated by tumor cells and mast cells, is also markedly increased and is one of the main immunosuppressive factors in the tumor environment.…”